Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/1999
08/11/1999EP0934937A1 Azole derivatives as superoxide radical inhibitor
08/11/1999EP0934931A2 3-Benzylidene-2-indolinones and their analogues as tyrosine kinase activity modulators
08/11/1999EP0934336A1 Novel compounds
08/11/1999EP0934320A1 Naphthyridine derivatives
08/11/1999EP0934314A1 N-substituted azaheterocyclic compounds
08/11/1999EP0934313A1 N-substituted azaheterocyclic compounds
08/11/1999EP0934312A1 1,4-disubstituted piperazines
08/11/1999EP0934307A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
08/11/1999EP0934306A1 N-substituted azaheterocyclic compounds
08/11/1999EP0934305A1 Integrin antagonists
08/11/1999EP0934300A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
08/11/1999EP0934293A1 Novel compounds and compositions for treating diseases associated with tryptase activity
08/11/1999EP0934292A1 Metalloproteinase inhibitors
08/11/1999EP0934291A1 Protease inhibitors
08/11/1999EP0934290A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same
08/11/1999EP0934280A1 Pde iv inhibiting 2-cyanoiminoimidazole derivatives
08/11/1999EP0934271A1 Substituted arylalkylamines as neurokinin antagonists
08/11/1999EP0934264A1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
08/11/1999EP0934074A1 Use of ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition containing such extract
08/11/1999EP0934068A1 Compounds and methods
08/11/1999EP0934063A1 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
08/11/1999EP0934061A1 Isobutylgaba and its derivatives for the treatment of pain
08/11/1999EP0934055A1 Clear cosmetic sticks and process for its preparation
08/11/1999EP0789706A4 Sugar modified nucleosides and their use for synthesis of oligonucleotides
08/11/1999EP0781282B1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
08/11/1999EP0678097B1 Novel colon- or ileum-specific steroid derivatives
08/11/1999EP0666741B1 Dithiocarbamates for the treatment of atherosclerosis and other cardiovascular and inflammatory diseases
08/11/1999CN1225639A Phosphinate based inhibitors of matrix metalloproteases
08/11/1999CN1225637A Pyrrole triazines and pyrimidines
08/11/1999CN1225629A Novel pyrrole derivatives
08/11/1999CN1225624A Inhibition of matrix metalloproteases by substituted phenethyl compounds
08/11/1999CN1225623A Inhibition of matrix metalloproteases by acetylene contg. compounds
08/11/1999CN1225622A Substituted oxobutyric acids as matrix metalloprotease inhibitor
08/11/1999CN1225621A Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
08/11/1999CN1225620A Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
08/11/1999CN1225589A Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its prodn. and its use
08/11/1999CN1225580A Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
08/11/1999CN1225555A Teat dipping agent
08/11/1999CN1225367A Bond partner, and use for sieving inhibitor and diagnosis and treatment of disease
08/11/1999CN1225360A Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them
08/10/1999US5936084 Halo-substituted bisindolemaleimide protein kinase C inhibitors
08/10/1999US5936065 CS-1 peptidomimetics, compositions and methods of using the same
08/10/1999US5935995 Poly-, oligo- and monosaccharides of drugs, e.g. nitrogen mustard gas, quinine and dipyridamole; stability; slow release; antiarthitic agents; enzyme inhibitors
08/10/1999US5935972 Benzofuran derivatives as tachykinin antagonists
08/10/1999US5935956 Pyridazine compounds
08/10/1999US5935931 Human apoptosis-related calcium-binding protein
08/10/1999US5935852 The present invention relates to a family of proteins designated as cerberus, which appears to be a pioneer protein, with a 9 cysteine residue pattern, which is present in the embryo.
08/10/1999US5935835 The invention relates to novel polynucleotides and polypeptides of the family of cdc-regulatory kinases, hereinafter referred to as human myt-1 kinase.
08/10/1999US5935820 Polynucleotides encoding vascular endothelial growth factor 2
08/10/1999US5935798 Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices
08/10/1999US5935602 Dosage forms of risedronate
08/10/1999US5935585 Novel compounds useful in topical and systemic treatment of dermatological conditions associated with a keratinization disorder, and inflammatory or immunoallergenic component; body and hair care cosmetics
08/10/1999US5935564 Use of hydrophobic interaction chromatography to purify polyethylene glycols
08/10/1999CA1340704C Human interferon-gamma, process to prepare said human interferon-gamma, and its use
08/05/1999WO1999038998A1 Methods of identifying modulators of kinases responsive to stress
08/05/1999WO1999038969A1 PROTEIN HUMAINE β-TrCP
08/05/1999WO1999038882A1 Human cystatin f
08/05/1999WO1999038877A2 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
08/05/1999WO1999038868A1 Azolo triazines and pyrimidines
08/05/1999WO1999038843A1 Hydroxamic and carboxylic acid derivatives
08/05/1999WO1999038532A2 Methods for the prevention and treatment of fibrosis and sclerosis
08/05/1999WO1999038484A1 Anti-enzyme compositions comprising ethylenediamine disuccinic acid
08/05/1999WO1999024398A3 Urea derivatives and their use as integrin inhibitors
08/05/1999WO1999021860B1 Phenanthroline derivatives
08/05/1999WO1999014322A3 Allelic variant of human stat3
08/05/1999DE19804376A1 Lipidmischungen sowie deren Verwendung Lipid mixtures and their use
08/05/1999CA2319081A1 Human cystatin f
08/05/1999CA2318780A1 Anti-enzyme compositions comprising ethylenediamine disuccinic acid
08/05/1999CA2318336A1 Methods for the prevention and treatment of fibrosis and sclerosis
08/05/1999CA2318278A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
08/05/1999CA2317459A1 Methods of identifying modulators of kinases responsive to stress
08/04/1999EP0933373A1 Terpenoid lactone compounds and their production process
08/04/1999EP0933366A1 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same
08/04/1999EP0933351A1 Tricyclic retinoids, methods for their production and use
08/04/1999EP0933350A1 Tricyclic retinoids, methods for their production and use
08/04/1999EP0932668A1 Two human cathepsin proteins
08/04/1999EP0932626A1 G protein-coupled receptor antagonists
08/04/1999EP0932618A1 Peptide analogues containing a 7-membered lactam ring
08/04/1999EP0932598A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
08/04/1999EP0932390A1 Therapeutic liposome composition and method
08/04/1999EP0871644A4 Platelet-endothelial cell adhesion molecule-1 compositions and methods
08/04/1999EP0854720B1 Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy
08/04/1999EP0759027B1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
08/04/1999EP0748311B1 Therapeutic benzonitriles
08/04/1999EP0744957B1 Composition and method for preventing and treating inflammation with immunoglobulin a
08/04/1999EP0740653B1 Hydroxamic acid derivatives as metalloproteinase inhibitors
08/04/1999EP0628038B1 3-ALKYLOXY-, ARYLOXY-, OR ARYLALKYLOXYBENZO [b]THIOPHENE-2-CARBOXAMIDES AS INHIBITORS OF CELL ADHESION
08/04/1999CN1225085A Substituted pyridines as selective cyclooxygenase-2 inhibitors
08/04/1999CN1225010A Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
08/04/1999CN1224720A Tetracylic derivatives, process of preparation and use
08/04/1999CN1224610A Ibuprofen compositions
08/03/1999US5932737 Peptide compounds for treatment of no-mediated diseases
08/03/1999US5932716 Disclosed herein are methods and compositions for identifying morphogen analogs.
08/03/1999US5932703 The present invention provides purified and isolated polynucleotide sequences encoding a novel human macrophage-derived c--c chemokine designated mdc, and polypeptide analogs thereof.
08/03/1999US5932610 Tumor necrosis factor α (TNF-α) inhibiting pharmaceuticals
08/03/1999US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors
08/03/1999US5932595 Antiarthritic agent; multiple sclerosis; osteoporosis; respiratory system disorders; skin disorders; antiulcer agent
08/03/1999US5932592 Quinoline or quinazoline derivatives, their production and use
08/03/1999US5932586 Prostaglandin synthase inhibitors
08/03/1999US5932580 PDGF receptor kinase inhibitory compounds their preparation and compositions
1 ... 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 ... 1272